Urogen Pharma Ltd (URGN)

EV/EBITDA

-26.40×

TTM · Retrieved:

URGN logo

URGN EV/EBITDA

Current (TTM)-26.40×
URGN Quarterly EV/EBITDA (-23.84× → -622.35×)
High-resolution chart · PNG

URGN ev/ebitda history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd EV/EBITDA — Quarterly
Period endingEV/EBITDA
-622.3502×
-51.9962×
-52.7564×
-38.7553×
-14.1055×
-14.0257×
-17.2283×
-37.083×
-16.3655×
-18.5386×
-73.6489×
-35.5314×
-16.1996×
-10.6057×
-10.1405×
-10.6726×
-9.8263×
-5.9576×
-8.7102×
-10.8109×
-10.9391×
-15.3387×
-13.0528×
-14.1139×
-17.0889×
-9.5161×
-16.8861×
-18.6068×
-28.3529×
-20.9475×
-24.9283×
-31.3853×
-36.2467×
-45.578×
-48.4159×
-1,161.5392×
-15.201×
-49.9836×
9.4313×
-26.2961×
-54.348×
-4.8162×
-2.0486×
-17.8759×
-23.8399×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.